George A. Joulwan, Director at Emergent BioSolutions Inc. (EBS), sold 2,000 shares at $85.19 ($170K) on 2020-05-11, disclosed to the SEC on 2020-05-13.
Seasonal sale ($170k) by Director — this insider has traded EBS in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| EBS | SELL | 2018-06-12 | $264K | — | Filing → |
| EBS | SELL | 2017-11-09 | $1.2M | — | Filing → |
| EBS | SELL | 2016-06-07 | $207K | — | Filing → |